25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Spectrascience New
Buy, Hold or Sell?

Let's analyze Spectrascience together

I guess you are interested in Spectrascience New. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Spectrascience New. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Spectrascience New

I send you an email if I find something interesting about Spectrascience New.

1. Quick Overview

1.1. Quick analysis of Spectrascience (30 sec.)










1.2. What can you expect buying and holding a share of Spectrascience? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$-0.01
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-2,889.8%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Spectrascience (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.00 - $0.00
Total Value Per Share
$0.00 - $-0.01

2.2. Growth of Spectrascience (5 min.)




Is Spectrascience growing?

Current yearPrevious yearGrowGrow %
How rich?-$10.5m-$6.9m-$3.5m-33.7%

How much money is Spectrascience making?

Current yearPrevious yearGrowGrow %
Making money-$4.4m-$3.6m-$831.6k-18.6%
Net Profit Margin-86,729.5%-55,073.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Spectrascience (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Spectrascience?

Welcome investor! Spectrascience's management wants to use your money to grow the business. In return you get a share of Spectrascience.

First you should know what it really means to hold a share of Spectrascience. And how you can make/lose money.

Speculation

The Price per Share of Spectrascience is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Spectrascience.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Spectrascience, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Spectrascience.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-907.1%0.00-907.1%0.00-738.2%0.00-623.1%0.00-311.5%
Usd Book Value Change Per Share0.00-722.5%0.00-722.5%0.00-529.7%0.00-530.2%0.00-224.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-722.5%0.00-722.5%0.00-529.7%0.00-530.2%0.00-224.9%
Usd Price Per Share0.00-0.00-0.00-0.02-0.19-
Price to Earnings Ratio-1.87--1.87--1.76--10.54--5.27-
Price-to-Total Gains Ratio-2.35--2.35--2.45--39.65-147.66-
Price to Book Ratio-0.79--0.79--0.92--42.60-91.09-
Price-to-Total Gains Ratio-2.35--2.35--2.45--39.65-147.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)-7,224.54-5,301.61
Gains per Year (10000000 shares)-28,898.18-21,206.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-28898-289080-21206-21216
20-57796-578060-42413-42422
30-86695-867040-63619-63628
40-115593-1156020-84826-84834
50-144491-1445000-106032-106040
60-173389-1733980-127239-127246
70-202287-2022960-148445-148452
80-231185-2311940-169652-169658
90-260084-2600920-190858-190864
100-288982-2889900-212064-212070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.01.00.0%0.04.06.00.0%1.04.011.06.3%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%4.012.00.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.016.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%4.012.00.025.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Spectrascience New compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%-0.001-27%-0.001-27%0.000-69%
Book Value Per Share---0.002-0.0020%-0.001-34%-0.001-51%0.000-1390%
Current Ratio--0.0330.0330%0.060-44%0.078-57%0.039-14%
Debt To Asset Ratio--8.6078.6070%4.744+81%4.016+114%2.050+320%
Debt To Equity Ratio----0%-0%0.318-100%0.211-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value---3561939.891-3561939.8910%-2454405.917-31%79015091.121-105%955119157.465-100%
Eps---0.001-0.0010%-0.001-19%-0.001-31%0.000-66%
Ev To Ebitda Ratio--infinfnan%infnan%nannan%nannan%
Ev To Sales Ratio---691.639-691.6390%-371.880-46%infnan%infnan%
Free Cash Flow Per Share--0.0000.0000%0.000+25%0.000+23%0.000+23%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000-25%0.000-83%0.000-83%
Gross Profit Margin--1.0001.0000%1.0000%0.800+25%0.400+150%
Intrinsic Value_10Y_max---0.003--------
Intrinsic Value_10Y_min---0.003--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max---0.001--------
Intrinsic Value_3Y_min---0.001--------
Intrinsic Value_5Y_max---0.002--------
Intrinsic Value_5Y_min---0.002--------
Market Cap492380.006-1600%8370460.1098370460.1090%6400940.083+31%86264977.121-90%958959300.465-99%
Net Profit Margin---867.295-867.2950%-550.738-36%-285.898-67%-142.949-84%
Operating Margin---474.599-474.5990%-376.269-21%-172.450-64%-86.225-82%
Operating Ratio--514.319514.3190%377.360+36%182.594+182%131.421+291%
Pb Ratio-0.047+94%-0.794-0.7940%-0.916+15%-42.599+5267%91.088-101%
Pe Ratio-0.110+94%-1.874-1.8740%-1.761-6%-10.541+462%-5.270+181%
Price Per Share0.000-1600%0.0020.0020%0.001+31%0.018-90%0.195-99%
Price To Free Cash Flow Ratio-0.325+94%-5.533-5.5330%-3.393-39%-18.941+242%-9.470+71%
Price To Total Gains Ratio-0.138+94%-2.353-2.3530%-2.454+4%-39.650+1585%147.657-102%
Quick Ratio--0.0000.0000%0.001-89%0.003-97%0.620-100%
Return On Assets---3.222-3.2220%-1.947-40%-1.676-48%-0.838-74%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.001-0.0010%-0.001-27%-0.001-27%0.000-69%
Usd Book Value---10546033.000-10546033.0000%-6988812.000-34%-5208528.400-51%817735.800-1390%
Usd Book Value Change Per Share---0.001-0.0010%-0.001-27%-0.001-27%0.000-69%
Usd Book Value Per Share---0.002-0.0020%-0.001-34%-0.001-51%0.000-1390%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value---3561939.891-3561939.8910%-2454405.917-31%79015091.121-105%955119157.465-100%
Usd Eps---0.001-0.0010%-0.001-19%-0.001-31%0.000-66%
Usd Free Cash Flow---1512731.000-1512731.0000%-1886437.000+25%-1492818.200-1%-746409.100-51%
Usd Free Cash Flow Per Share--0.0000.0000%0.000+25%0.000+23%0.000+23%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000-25%0.000-83%0.000-83%
Usd Market Cap492380.006-1600%8370460.1098370460.1090%6400940.083+31%86264977.121-90%958959300.465-99%
Usd Price Per Share0.000-1600%0.0020.0020%0.001+31%0.018-90%0.195-99%
Usd Profit---4466567.000-4466567.0000%-3634868.000-19%-3067872.200-31%-1533936.100-66%
Usd Revenue--5150.0005150.0000%6600.000-22%142550.000-96%99175.000-95%
Usd Total Gains Per Share---0.001-0.0010%-0.001-27%-0.001-27%0.000-69%
 EOD+2 -6MRQTTM+0 -0YOY+9 -255Y+6 -2910Y+6 -29

3.3 Fundamental Score

Let's check the fundamental score of Spectrascience New based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.110
Price to Book Ratio (EOD)Between0-1-0.047
Net Profit Margin (MRQ)Greater than0-867.295
Operating Margin (MRQ)Greater than0-474.599
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.033
Debt to Asset Ratio (MRQ)Less than18.607
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.222
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Spectrascience New based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Spectrascience New

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

Fundamental data was last updated by Penke on 2024-11-28 02:14:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Spectrascience earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Spectrascience to the Medical Devices industry mean.
  • A Net Profit Margin of -86,729.5% means that $-867.29 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Spectrascience New:

  • The MRQ is -86,729.5%. The company is making a huge loss. -2
  • The TTM is -86,729.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-86,729.5%TTM-86,729.5%0.0%
TTM-86,729.5%YOY-55,073.8%-31,655.7%
TTM-86,729.5%5Y-28,589.8%-58,139.7%
5Y-28,589.8%10Y-14,294.9%-14,294.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-86,729.5%-6.4%-86,723.1%
TTM-86,729.5%-14.9%-86,714.6%
YOY-55,073.8%-15.4%-55,058.4%
5Y-28,589.8%-17.9%-28,571.9%
10Y-14,294.9%-21.7%-14,273.2%
4.3.1.2. Return on Assets

Shows how efficient Spectrascience is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Spectrascience to the Medical Devices industry mean.
  • -322.2% Return on Assets means that Spectrascience generated $-3.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Spectrascience New:

  • The MRQ is -322.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -322.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-322.2%TTM-322.2%0.0%
TTM-322.2%YOY-194.7%-127.4%
TTM-322.2%5Y-167.6%-154.6%
5Y-167.6%10Y-83.8%-83.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-322.2%-2.1%-320.1%
TTM-322.2%-3.2%-319.0%
YOY-194.7%-4.0%-190.7%
5Y-167.6%-3.0%-164.6%
10Y-83.8%-4.0%-79.8%
4.3.1.3. Return on Equity

Shows how efficient Spectrascience is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Spectrascience to the Medical Devices industry mean.
  • 0.0% Return on Equity means Spectrascience generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Spectrascience New:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.4%+2.4%
TTM--3.9%+3.9%
YOY--4.5%+4.5%
5Y--4.0%+4.0%
10Y--5.5%+5.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Spectrascience New.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Spectrascience is operating .

  • Measures how much profit Spectrascience makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Spectrascience to the Medical Devices industry mean.
  • An Operating Margin of -47,459.9% means the company generated $-474.60  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Spectrascience New:

  • The MRQ is -47,459.9%. The company is operating very inefficient. -2
  • The TTM is -47,459.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-47,459.9%TTM-47,459.9%0.0%
TTM-47,459.9%YOY-37,626.9%-9,833.0%
TTM-47,459.9%5Y-17,245.0%-30,214.9%
5Y-17,245.0%10Y-8,622.5%-8,622.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-47,459.9%-13.1%-47,446.8%
TTM-47,459.9%-20.2%-47,439.7%
YOY-37,626.9%-13.7%-37,613.2%
5Y-17,245.0%-16.5%-17,228.5%
10Y-8,622.5%-20.9%-8,601.6%
4.3.2.2. Operating Ratio

Measures how efficient Spectrascience is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 514.32 means that the operating costs are $514.32 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Spectrascience New:

  • The MRQ is 514.319. The company is inefficient in keeping operating costs low. -1
  • The TTM is 514.319. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ514.319TTM514.3190.000
TTM514.319YOY377.360+136.959
TTM514.3195Y182.594+331.725
5Y182.59410Y131.421+51.173
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ514.3191.203+513.116
TTM514.3191.305+513.014
YOY377.3601.328+376.032
5Y182.5941.366+181.228
10Y131.4211.312+130.109
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Spectrascience New.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Spectrascience is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.03 means the company has $0.03 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Spectrascience New:

  • The MRQ is 0.033. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.033. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.033TTM0.0330.000
TTM0.033YOY0.060-0.026
TTM0.0335Y0.078-0.044
5Y0.07810Y0.039+0.039
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0332.567-2.534
TTM0.0332.707-2.674
YOY0.0602.888-2.828
5Y0.0783.435-3.357
10Y0.0393.527-3.488
4.4.3.2. Quick Ratio

Measures if Spectrascience is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Spectrascience to the Medical Devices industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Spectrascience New:

  • The MRQ is 0.000. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.000. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.000TTM0.0000.000
TTM0.000YOY0.001-0.001
TTM0.0005Y0.003-0.003
5Y0.00310Y0.620-0.618
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0001.442-1.442
TTM0.0001.678-1.678
YOY0.0011.892-1.891
5Y0.0032.299-2.296
10Y0.6202.555-1.935
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Spectrascience New.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Spectrascience assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Spectrascience to Medical Devices industry mean.
  • A Debt to Asset Ratio of 8.61 means that Spectrascience assets are financed with 860.7% credit (debt) and the remaining percentage (100% - 860.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Spectrascience New:

  • The MRQ is 8.607. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 8.607. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ8.607TTM8.6070.000
TTM8.607YOY4.744+3.863
TTM8.6075Y4.016+4.591
5Y4.01610Y2.050+1.966
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6070.401+8.206
TTM8.6070.401+8.206
YOY4.7440.362+4.382
5Y4.0160.431+3.585
10Y2.0500.453+1.597
4.5.4.2. Debt to Equity Ratio

Measures if Spectrascience is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Spectrascience to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Spectrascience New:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.318-0.318
5Y0.31810Y0.211+0.108
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.565-0.565
TTM-0.600-0.600
YOY-0.535-0.535
5Y0.3180.635-0.317
10Y0.2110.712-0.501
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Spectrascience generates.

  • Above 15 is considered overpriced but always compare Spectrascience to the Medical Devices industry mean.
  • A PE ratio of -1.87 means the investor is paying $-1.87 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Spectrascience New:

  • The EOD is -0.110. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.874. Based on the earnings, the company is expensive. -2
  • The TTM is -1.874. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.110MRQ-1.874+1.764
MRQ-1.874TTM-1.8740.000
TTM-1.874YOY-1.761-0.113
TTM-1.8745Y-10.541+8.667
5Y-10.54110Y-5.270-5.270
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.110-0.959+0.849
MRQ-1.874-1.344-0.530
TTM-1.874-1.807-0.067
YOY-1.761-2.324+0.563
5Y-10.541-2.138-8.403
10Y-5.270-1.952-3.318
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Spectrascience New:

  • The EOD is -0.325. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.533. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.533. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.325MRQ-5.533+5.208
MRQ-5.533TTM-5.5330.000
TTM-5.533YOY-3.393-2.140
TTM-5.5335Y-18.941+13.408
5Y-18.94110Y-9.470-9.470
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.325-1.459+1.134
MRQ-5.533-1.910-3.623
TTM-5.533-2.233-3.300
YOY-3.393-5.444+2.051
5Y-18.941-4.008-14.933
10Y-9.470-4.828-4.642
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Spectrascience is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -0.79 means the investor is paying $-0.79 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Spectrascience New:

  • The EOD is -0.047. Based on the equity, the company is expensive. -2
  • The MRQ is -0.794. Based on the equity, the company is expensive. -2
  • The TTM is -0.794. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.047MRQ-0.794+0.747
MRQ-0.794TTM-0.7940.000
TTM-0.794YOY-0.916+0.122
TTM-0.7945Y-42.599+41.806
5Y-42.59910Y91.088-133.688
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0472.149-2.196
MRQ-0.7942.142-2.936
TTM-0.7942.344-3.138
YOY-0.9163.005-3.921
5Y-42.5994.023-46.622
10Y91.0884.497+86.591
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2016-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,386
Total Liabilities11,932
Total Stockholder Equity-10,546
 As reported
Total Liabilities 11,932
Total Stockholder Equity+ -10,546
Total Assets = 1,386

Assets

Total Assets1,386
Total Current Assets362
Long-term Assets1,025
Total Current Assets
Cash And Cash Equivalents 4
Net Receivables 1
Inventory 91
Total Current Assets  (as reported)362
Total Current Assets  (calculated)95
+/- 267
Long-term Assets
Intangible Assets 1,025
Long-term Assets  (as reported)1,025
Long-term Assets  (calculated)1,025
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,802
Long-term Liabilities1,131
Total Stockholder Equity-10,546
Total Current Liabilities
Short-term Debt 6,385
Short Long Term Debt 6,385
Accounts payable 1,319
Other Current Liabilities 820
Total Current Liabilities  (as reported)10,802
Total Current Liabilities  (calculated)14,908
+/- 4,107
Long-term Liabilities
Long term Debt 1,100
Long-term Liabilities  (as reported)1,131
Long-term Liabilities  (calculated)1,100
+/- 31
Total Stockholder Equity
Common Stock8,837
Total Stockholder Equity (as reported)-10,546
Total Stockholder Equity (calculated)8,837
+/- 19,383
Other
Net Tangible Assets -11,571
Net Working Capital -10,440
Preferred Stock Total Equity 31



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
4,370
1,835
458
281
1,634
892
593
10,633
7,236
8,106
7,050
3,347
2,413
2,330
2,211
1,867
1,386
1,3861,8672,2112,3302,4133,3477,0508,1067,23610,6335938921,6342814581,8354,370
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
801
859
531
362
3625318598010000000000000
       Cash And Cash Equivalents 
3,735
970
227
73
1,133
441
175
5,188
1,618
3,408
1,765
251
90
237
224
127
4
4127224237902511,7653,4081,6185,1881754411,133732279703,735
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
1,999
0
0
0
0
0
0
0000001,9990000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
60
0
7
1
170600000000000000
       Other Current Assets 
88
87
23
0
54
42
51
41
85
196
69
24
357
82
108
365
0
036510882357246919685415142540238788
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,025
1,0250000000000000000
       Property Plant Equipment 
268
198
58
58
16
6
0
944
1,877
1,140
59
244
86
16
4
0
0
0041686244591,1401,87794406165858198268
       Intangible Assets 
0
0
0
0
282
263
243
3,415
3,166
2,916
2,667
2,433
1,678
1,513
1,348
1,185
1,025
1,0251,1851,3481,5131,6782,4332,6672,9163,1663,4152432632820000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,025
1,0250000000000000000
> Total Liabilities 
509
359
1,116
1,162
20
32
67
167
434
387
323
841
3,989
4,882
6,591
8,855
11,932
11,9328,8556,5914,8823,9898413233874341676732201,1621,116359509
   > Total Current Liabilities 
509
359
21
24
20
32
67
167
434
387
323
841
3,989
4,882
6,591
8,855
10,802
10,8028,8556,5914,8823,9898413233874341676732202421359509
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,337
4,020
5,883
6,385
6,3855,8834,0202,3370000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,337
4,020
5,883
6,385
6,3855,8834,0202,3370000000000000
       Accounts payable 
118
178
0
0
13
17
58
155
346
220
205
696
862
1,009
836
941
1,319
1,3199418361,00986269620522034615558171300178118
       Other Current Liabilities 
343
131
21
24
7
15
9
12
88
167
118
145
2,519
1,104
1,062
620
820
8206201,0621,1042,519145118167881291572421131343
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,131
1,1310000000000000000
       Other Liabilities 
0
0
1,095
1,138
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,1381,09500
> Total Stockholder Equity
3,861
1,476
0
0
1,614
860
526
10,466
6,802
7,719
6,727
2,506
0
-2,582
-4,411
-7,020
-10,546
-10,546-7,020-4,411-2,58202,5066,7277,7196,80210,4665268601,614001,4763,861
   Common Stock
1,751
1,788
1,788
1,788
376
376
384
590
686
702
1,080
1,080
1,522
1,667
1,944
4,312
8,837
8,8374,3121,9441,6671,5221,0801,0807026865903843763761,7881,7881,7881,751
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 00000000000000000
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 00000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2016-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue5
Cost of Revenue-199
Gross Profit-194-194
 
Operating Income (+$)
Gross Profit-194
Operating Expense-2,449
Operating Income-2,444-2,644
 
Operating Expense (+$)
Research Development637
Selling General Administrative1,613
Selling And Marketing Expenses0
Operating Expense2,4492,250
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-1,155
Net Interest Income-1,155
 
Pretax Income (+$)
Operating Income-2,444
Net Interest Income-1,155
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,467-1,577
EBIT - interestExpense = -2,444
-4,467
-4,467
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-2,444-4,467
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-4,467
Tax Provision-0
Net Income From Continuing Ops-4,467-4,467
Net Income-4,467
Net Income Applicable To Common Shares-4,467
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-8671,155
 

Technical Analysis of Spectrascience
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Spectrascience. The general trend of Spectrascience is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Spectrascience's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Spectrascience New.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Spectrascience New Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Spectrascience New. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Spectrascience New Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Spectrascience New. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Spectrascience price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Spectrascience. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Spectrascience price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Spectrascience New Daily Moving Average Convergence/Divergence (MACD) ChartSpectrascience New Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Spectrascience New. The current adx is 37.56.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Spectrascience shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Spectrascience New Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Spectrascience New. The current sar is 0.00010001.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Spectrascience New Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Spectrascience New. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Spectrascience New Daily Relative Strength Index (RSI) ChartSpectrascience New Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Spectrascience New. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Spectrascience price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Spectrascience New Daily Stochastic Oscillator ChartSpectrascience New Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Spectrascience New. The current cci is -666.66666667.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Spectrascience New Daily Commodity Channel Index (CCI) ChartSpectrascience New Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Spectrascience New. The current cmo is 0.

Spectrascience New Daily Chande Momentum Oscillator (CMO) ChartSpectrascience New Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Spectrascience New. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Spectrascience New Daily Williams %R ChartSpectrascience New Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Spectrascience New.

Spectrascience New Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Spectrascience New. The current atr is 0.00001.

Spectrascience New Daily Average True Range (ATR) ChartSpectrascience New Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Spectrascience New. The current obv is 7,113,453,293.

Spectrascience New Daily On-Balance Volume (OBV) ChartSpectrascience New Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Spectrascience New. The current mfi is 0.0000.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Spectrascience New Daily Money Flow Index (MFI) ChartSpectrascience New Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Spectrascience New.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Spectrascience New Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Spectrascience New based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Spectrascience with someone you think should read this too:
  • Are you bullish or bearish on Spectrascience? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Spectrascience? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Spectrascience New

I send you an email if I find something interesting about Spectrascience New.


Comments

How you think about this?

Leave a comment

Stay informed about Spectrascience New.

Receive notifications about Spectrascience New in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.